HER2-targeted therapy in practice

With Nicolas Girard

An interactive case study covering targeted therapy options for HER2 mutation-positive NSCLC, with guidance on how you can best support patients on these therapies as an APP.

Register to access

Learning objectives

After completing this activity, you will be able to:

Support multidisciplinary teams by applying current evidence on biomarker testing and HER2-targeted therapies to real-world patient care
Implement evidence-based approaches for managing treatment-related toxicities in patients with HER2 mutation-positive NSCLC

Content overview

These case studies are available with video and text. The activity is best supported via a computer or mobile device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari.

Release date: 10^th July 2026

Estimated time to complete: 20 minutes

Accreditation

This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of 0.25 International Continuing Nursing Education Credits (ICNECs) upon successful completion of the accredited course.

How to claim your credits

To claim your credits, you will need to complete the activity module, then fill out the short evaluation form at the end of the module. Physicians should claim only the credit commensurate with the extent of their participation in the activity.